Terms: = Colorectal cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Prognosis
95 results:
1. Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy.
Giatromanolaki A; Kavazis C; Gkegka AG; Kouroupi M; Tsaroucha A; Pitiakoudis M; Koukourakis MI
Immunobiology; 2023 Nov; 228(6):152756. PubMed ID: 38860277
[TBL] [Abstract] [Full Text] [Related]
2. The Relationship of Microsatellite Instability with BRAF and p53 Mutations and Histopathological Parameters in colorectal Adenocarcinoma.
Gündoğar Ö; Bektaş S; Yıldırım E; Gönüllü D
Ann Ital Chir; 2024; 95(2):181-191. PubMed ID: 38684491
[TBL] [Abstract] [Full Text] [Related]
3. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
4. Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.
Kato MK; Fujii E; Asami Y; Momozawa Y; Hiranuma K; Komatsu M; Hamamoto R; Ebata T; Matsumoto K; Ishikawa M; Kohno T; Kato T; Yoshida H; Shiraishi K
Cancer Sci; 2024 May; 115(5):1646-1655. PubMed ID: 38433331
[TBL] [Abstract] [Full Text] [Related]
5. colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
Ho YH; Hsu CY; Yau Li AF; Liang WY
Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
[TBL] [Abstract] [Full Text] [Related]
6. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
[No Abstract] [Full Text] [Related]
8. Mismatch Repair Deficiency in Biliary Tract cancer: Prognostic Implications and Correlation with Histology.
Vivaldi C; Genovesi V; Ugolini C; Bernardini L; Casadei-Gardini A; Formica V; Salani F; Orsi G; Massa V; Cacciato-Insilla A; Caccese M; Cesario S; Andrikou K; Graziani J; Campani D; Vasile E; Fontanini G; Fornaro L; Masi G
Oncology; 2024; 102(2):157-167. PubMed ID: 37699372
[TBL] [Abstract] [Full Text] [Related]
9. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types.
Bartels S; Grote I; Wagner M; Boog J; Schipper E; Reineke-Plaass T; Kreipe H; Lehmann U
Cancer Med; 2023 Aug; 12(16):16707-16715. PubMed ID: 37376830
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
[TBL] [Abstract] [Full Text] [Related]
11. Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon cancers and 5-FU Resistance.
Cui Z; He S; Wen F; Lu L; Xu L; Wu H; Wu S
Front Biosci (Landmark Ed); 2023 Apr; 28(4):80. PubMed ID: 37114540
[TBL] [Abstract] [Full Text] [Related]
12. A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples.
Zhang Z; Wan H; Xu B; He H; Shan G; Zhang J; Wu Q; Li T
Chin Med J (Engl); 2023 May; 136(9):1082-1088. PubMed ID: 37022939
[TBL] [Abstract] [Full Text] [Related]
13. Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.
Kansikas M; Vähätalo L; Kantelinen J; Kasela M; Putula J; Døhlen A; Paloviita P; Kärkkäinen E; Lahti N; Arnez P; Kilpinen S; Alcala-Repo B; Pylvänäinen K; Pöyhönen M; Peltomäki P; Järvinen HJ; Seppälä TT; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Nyström M
Cancer Res Commun; 2023 Mar; 3(3):361-370. PubMed ID: 36875157
[TBL] [Abstract] [Full Text] [Related]
14. An exploration of gastric cancer with heterogeneous mismatch repair status.
Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y
Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896
[TBL] [Abstract] [Full Text] [Related]
15. [Microsatellite instability in gastric cancer is a predictor of a favorable prognosis].
Danilova NV; Chayka AV; Khomyakov VM; Oleynikova NA; Andreeva YY; Malkov PG
Arkh Patol; 2022; 84(6):5-15. PubMed ID: 36469712
[TBL] [Abstract] [Full Text] [Related]
16. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
Li K; Liu Y; Han J; Gui J; Zhang X
Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
[TBL] [Abstract] [Full Text] [Related]
17. A genetic map of the chromatin regulators to drug response in cancer cells.
Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer.
Kim JH; Kwon BS; Kim H; Suh DH; Kim K; Kim YB; No JH
Taiwan J Obstet Gynecol; 2022 May; 61(3):415-421. PubMed ID: 35595431
[TBL] [Abstract] [Full Text] [Related]
19. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
[TBL] [Abstract] [Full Text] [Related]
20. The clinical features and management of Lynch syndrome-associated ovarian cancer.
Ran X; Jing H; Li Z
J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
[TBL] [Abstract] [Full Text] [Related]
[Next]
